294 related articles for article (PubMed ID: 25244654)
21. Bone morphogenetic protein-7 delays podocyte injury due to high glucose.
De Petris L; Hruska KA; Chiechio S; Liapis H
Nephrol Dial Transplant; 2007 Dec; 22(12):3442-50. PubMed ID: 17686813
[TBL] [Abstract][Full Text] [Related]
22. Activation of aryl hydrocarbon receptor mediates suppression of hypoxia-inducible factor-dependent erythropoietin expression by indoxyl sulfate.
Asai H; Hirata J; Hirano A; Hirai K; Seki S; Watanabe-Akanuma M
Am J Physiol Cell Physiol; 2016 Jan; 310(2):C142-50. PubMed ID: 26561638
[TBL] [Abstract][Full Text] [Related]
23. Aryl hydrocarbon receptor (AhR) and its endogenous agonist - indoxyl sulfate in chronic kidney disease.
Kamiński T; Michałowska M; Pawlak D
Postepy Hig Med Dosw (Online); 2017 Jul; 71(0):624-632. PubMed ID: 28791957
[TBL] [Abstract][Full Text] [Related]
24. Roles of AhR/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy.
Lu W; Cheng S; Xu J; Xiao Z; Yu Y; Xie Q; Fang Y; Chen R; Shen B; Xie Y; Ding X
Toxicol Lett; 2024 May; 396():81-93. PubMed ID: 38670245
[TBL] [Abstract][Full Text] [Related]
25. Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated.
Wakamatsu T; Yamamoto S; Ito T; Sato Y; Matsuo K; Takahashi Y; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29543732
[TBL] [Abstract][Full Text] [Related]
26. Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings.
Nguyen C; Edgley AJ; Kelly DJ; Kompa AR
Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202128
[TBL] [Abstract][Full Text] [Related]
27. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
[TBL] [Abstract][Full Text] [Related]
28. ARHGEF7 (
Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
[TBL] [Abstract][Full Text] [Related]
29. Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury.
Blattner SM; Hodgin JB; Nishio M; Wylie SA; Saha J; Soofi AA; Vining C; Randolph A; Herbach N; Wanke R; Atkins KB; Gyung Kang H; Henger A; Brakebusch C; Holzman LB; Kretzler M
Kidney Int; 2013 Nov; 84(5):920-30. PubMed ID: 23677246
[TBL] [Abstract][Full Text] [Related]
30. Uremic toxicity of indoxyl sulfate.
Niwa T
Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
[TBL] [Abstract][Full Text] [Related]
31. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
32. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway.
Gondouin B; Cerini C; Dou L; Sallée M; Duval-Sabatier A; Pletinck A; Calaf R; Lacroix R; Jourde-Chiche N; Poitevin S; Arnaud L; Vanholder R; Brunet P; Dignat-George F; Burtey S
Kidney Int; 2013 Oct; 84(4):733-44. PubMed ID: 23636172
[TBL] [Abstract][Full Text] [Related]
33. Synaptopodin Is Dispensable for Normal Podocyte Homeostasis but Is Protective in the Context of Acute Podocyte Injury.
Ning L; Suleiman HY; Miner JH
J Am Soc Nephrol; 2020 Dec; 31(12):2815-2832. PubMed ID: 32938649
[TBL] [Abstract][Full Text] [Related]
34. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased EGFR expression by activating AhR and Akt.
Ichisaka Y; Yano S; Nishimura K; Niwa T; Shimizu H
Biomed Res; 2024; 45(2):57-66. PubMed ID: 38556263
[TBL] [Abstract][Full Text] [Related]
35. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.
Veron D; Villegas G; Aggarwal PK; Bertuccio C; Jimenez J; Velazquez H; Reidy K; Abrahamson DR; Moeckel G; Kashgarian M; Tufro A
PLoS One; 2012; 7(7):e40589. PubMed ID: 22808199
[TBL] [Abstract][Full Text] [Related]
36. TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular Damage.
Lu CL; Liao CH; Lu KC; Ma MC
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867359
[TBL] [Abstract][Full Text] [Related]
37. Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD).
Kim HY; Yoo TH; Hwang Y; Lee GH; Kim B; Jang J; Yu HT; Kim MC; Cho JY; Lee CJ; Kim HC; Park S; Lee WW
Sci Rep; 2017 Jun; 7(1):3057. PubMed ID: 28596556
[TBL] [Abstract][Full Text] [Related]
38. Role of Resveratrol on Indoxyl Sulfate-Induced Endothelial Hyperpermeability via Aryl Hydrocarbon Receptor (AHR)/Src-Dependent Pathway.
Assefa EG; Yan Q; Gezahegn SB; Salissou MTM; He S; Wu N; Zuo X; Ying C
Oxid Med Cell Longev; 2019; 2019():5847040. PubMed ID: 31885805
[TBL] [Abstract][Full Text] [Related]
39. Indoxyl-sulfate activation of the AhR- NF-κB pathway promotes interleukin-6 secretion and the subsequent osteogenic differentiation of human valvular interstitial cells from the aortic valve.
Candellier A; Issa N; Grissi M; Brouette T; Avondo C; Gomila C; Blot G; Gubler B; Touati G; Bennis Y; Caus T; Brazier M; Choukroun G; Tribouilloy C; Kamel S; Boudot C; Hénaut L;
J Mol Cell Cardiol; 2023 Jun; 179():18-29. PubMed ID: 36967106
[TBL] [Abstract][Full Text] [Related]
40. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?
Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D
Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
